A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris

NCT02164084 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: SB204
DRUG: Vehicle Gel

Sponsor

Novan, Inc.